Cinnamon: Benefits, Forms, Dosing, and Side Effects

Cinnamon is a spice derived from the inner bark of several evergreen trees in the genus Cinnamomum, cultivated primarily in South and Southeast Asia [1][2]. It has been used for thousands of years as both a flavoring agent and a traditional remedy for conditions ranging from digestive complaints to parasitic infections [1][3]. In recent decades, cinnamon has attracted significant scientific interest for its potential effects on blood sugar regulation, cholesterol, inflammation, and antioxidant defense.

There are two broad categories of cinnamon available commercially. Cassia cinnamon is the most commonly sold variety in the United States and globally, including several species: Cinnamomum cassia (Chinese cassia), Cinnamomum burmannii (Indonesian cassia or Korintje), and Cinnamomum loureiroi (Saigon or Vietnamese cassia). Cassia varieties account for over 90% of global cinnamon production due to higher yields and lower costs [2][4]. They have a bold, spicy flavor with higher cinnamaldehyde content and contain substantially higher levels of coumarin, a naturally occurring compound with potential liver toxicity [1][2][4].

Ceylon cinnamon (Cinnamomum verum or Cinnamomum zeylanicum), also called "true" cinnamon, is more expensive, less commonly available, and has a milder, sweeter flavor. Ceylon cinnamon contains only trace amounts of coumarin (approximately 0.004% dry weight versus 0.1-1% or higher in cassia varieties), making it the safer choice for regular or high-dose use [1][2][4][5].

The primary bioactive compounds in cinnamon include proanthocyanidins (PACs), which are polyphenols believed to enhance insulin activity and may inhibit digestive enzymes involved in starch-to-sugar conversion [1][6][7]; cinnamaldehyde, the predominant volatile compound responsible for cinnamon's warm flavor and demonstrated antimicrobial, anti-inflammatory, and antioxidant properties [2][4][8]; and coumarin, a natural anticoagulant that is hepatotoxic at high chronic doses [1][5][9][10].

Most clinical research has been conducted using cassia varieties, though limited evidence suggests Ceylon cinnamon may have similar glucose-lowering potential [1][11]. The key safety distinction is coumarin content: regular use of cassia cinnamon at supplemental doses may exceed safe coumarin thresholds, while Ceylon cinnamon carries minimal risk [1][2][5].

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Overview

Cinnamon is a spice derived from the inner bark of several evergreen trees in the genus Cinnamomum, cultivated primarily in South and Southeast Asia [1][2]. It has been used for thousands of years as both a flavoring agent and a traditional remedy for conditions ranging from digestive complaints to parasitic infections [1][3]. In recent decades, cinnamon has attracted significant scientific interest for its potential effects on blood sugar regulation, cholesterol, inflammation, and antioxidant defense.

There are two broad categories of cinnamon available commercially:

Cassia cinnamon — the most commonly sold variety in the United States and globally. This includes several species: Cinnamomum cassia (Chinese cassia), Cinnamomum burmannii (Indonesian cassia or Korintje), and Cinnamomum loureiroi (Saigon or Vietnamese cassia). Cassia varieties account for over 90% of global cinnamon production due to higher yields and lower costs [2][4]. They have a bold, spicy flavor with higher cinnamaldehyde content (up to 2-3% of bark weight) and contain substantially higher levels of coumarin, a naturally occurring compound with potential liver toxicity [1][2][4].

Ceylon cinnamon (Cinnamomum verum or Cinnamomum zeylanicum) — also called "true" cinnamon. It is more expensive, less commonly available, and has a milder, sweeter flavor with citrus and clove notes. Ceylon cinnamon contains only trace amounts of coumarin (approximately 0.004% dry weight versus 0.1-1% or higher in cassia varieties), making it the safer choice for regular or high-dose use [1][2][4][5].

The primary bioactive compounds in cinnamon include:

• Proanthocyanidins (PACs) — a class of polyphenols consisting of linked flavanol units, characterized by their "degree of polymerization" (DP-1 through DP-7 and higher). PACs are believed to enhance insulin activity and may inhibit digestive enzymes involved in starch-to-sugar conversion, which could explain cinnamon's blood sugar-lowering effects [1][6][7]. Type A proanthocyanidins, particularly abundant in cinnamon, are the primary compounds of interest in clinical research on glucose metabolism.
• Cinnamaldehyde — the predominant volatile compound in cinnamon essential oil, comprising 65-95% of the oil depending on species. It is responsible for cinnamon's characteristic warm flavor and has demonstrated antimicrobial, anti-inflammatory, and antioxidant activity in laboratory studies [2][4][8]. Cassia cinnamon contains higher concentrations than Ceylon.
• Coumarin — a bittersweet aromatic compound with natural anticoagulant properties. Coumarin interferes with an enzyme involved in converting vitamin K to a form needed for blood clot formation (the same mechanism exploited by the prescription blood thinner warfarin, which is a coumarin derivative) [1][9]. At high chronic doses, coumarin is hepatotoxic and has shown tumor-promoting potential in animal models [1][5][10].
• Additional compounds — eugenol (up to 10% in leaf oils), cinnamic acid, catechins, protocatechuic acid, linalool, and benzyl benzoate contribute to flavor, fragrance, and synergistic bioactivities [2][4].

Most clinical research on cinnamon's health benefits has been conducted using cassia varieties, though limited evidence suggests Ceylon cinnamon may have similar glucose-lowering potential [1][11]. The key safety distinction is coumarin content: regular use of cassia cinnamon at supplemental doses may exceed safe coumarin thresholds, while Ceylon cinnamon carries minimal coumarin-related risk [1][2][5].

Forms and Bioavailability

Cinnamon supplements come in several forms, each with distinct characteristics affecting their composition, PAC delivery, and coumarin content.

Ground Bark Powder

The simplest and most traditional form. Ground cinnamon bark is encapsulated or sold as loose powder. Clinical studies have used doses ranging from 1 to 6 grams per day. Ground bark powder contains both water-soluble compounds (PACs, polyphenols) and fat-soluble compounds (cinnamaldehyde, coumarin, essential oils) [1].

One study suggested that taking ground cinnamon as a powder mixed in water was substantially more effective than capsules for minimizing a blood sugar spike after a carbohydrate-rich meal [12]. In that study, 3 or 6 grams of ground cinnamon taken as powder immediately reduced postprandial glucose more effectively than the same dose in capsule form, likely because the powder was immediately available to inhibit starch-converting enzymes while capsules required time to disintegrate. However, the study only measured effects over a 2-hour period, and capsule-based cinnamon has demonstrated longer-term blood sugar-lowering effects in multiple trials [1][12].

PAC levels in bark powders vary considerably depending on species, growing conditions, and processing. This variability is one limitation of ground bark supplements compared to standardized extracts [1].

Water-Soluble Extracts

Concentrated extracts made by extracting cinnamon bark with water, which preferentially captures the water-soluble PACs while reducing fat-soluble coumarin. Two proprietary extracts have been studied in clinical trials:

Cinnulin PF — a water-soluble extract (20:1 concentration ratio) of Cinnamomum cassia standardized to 1% doubly-linked type-A PACs. Studied in prediabetic populations at 250 mg twice daily (500 mg/day total) with demonstrated reductions in fasting blood sugar and systolic blood pressure [13].

CinSulin — another water extract of cassia cinnamon studied at 250 mg twice daily, with modest effects on fasting blood sugar in adults with elevated glucose levels [14].

Water-soluble extracts are designed to deliver higher PAC concentrations per dose than ground bark powder, with reduced coumarin exposure. However, since coumarin is only weakly soluble in water, water extraction does not completely eliminate it — residual coumarin may still be present [1].

Cinnamon Oil

Derived by steam distillation of cinnamon bark. The essential oil contains cinnamaldehyde as its main constituent (60-90%) and may contain small amounts of coumarin (0.1-8.4% in cassia varieties) [15][16]. PACs are present in only minor amounts, if at all, in cinnamon oil [17]. Cinnamon oil products are typically used for aromatherapy and are not recommended for oral use as supplements. They lack the PAC content believed to mediate blood sugar-lowering effects.

Cinnamon Sticks

Rolled cinnamon bark, typically steeped in beverages rather than consumed whole. Cinnamon sticks likely contain the same coumarin concentration as an equivalent amount of bark powder. A 5-gram stick of cassia cinnamon could easily contain 25 mg or more of coumarin — a dangerous amount if consumed daily [18]. Coumarin is only weakly soluble in cold and warm water but slightly more so in hot water and highly soluble in alcohol and fats. Steeping a cinnamon stick in very hot or boiling beverages, or beverages containing alcohol or fats (milk, cream), may increase coumarin release. For regular use, Ceylon cinnamon sticks are preferable due to their substantially lower coumarin content [1][18].

Comparison of Cinnamon Species

Species	Common Name	Primary Region	Coumarin Content	Cinnamaldehyde	Key Safety Consideration
C. verum	Ceylon / "true" cinnamon	Sri Lanka	~0.004% (trace)	0.5-1%	Low hepatotoxicity risk; suitable for regular high-dose use
C. cassia	Chinese cassia	Southern China	0.1-0.8%	1-3%	Moderate coumarin; potential liver strain with excess intake
C. burmannii	Indonesian cassia (Korintje)	Indonesia	0.2-1.0%	1-3%	Higher coumarin; limits safe consumption to ~1 tsp/day
C. loureiroi	Saigon / Vietnamese cassia	Vietnam	Up to 6-7 mg/g	Up to 5%	Highest coumarin; greatest toxicity risk in large quantities

Sources: [1][2][4][5][19]

Form Selection Guidance

• For blood sugar support: Standardized water-soluble extracts (Cinnulin PF, CinSulin) at 250-500 mg/day provide consistent PAC delivery with reduced coumarin exposure. Ground cassia bark powder at 1-2 g/day is a lower-cost alternative but carries more coumarin and variable PAC content.
• For regular daily use: Ceylon cinnamon is preferred due to minimal coumarin risk, regardless of form.
• For acute postprandial glucose management: Ground cinnamon powder mixed in water (not capsules) may provide faster enzyme inhibition at mealtime [12].
• Cinnamon oil: Not suitable for oral supplementation; lacks PACs.

Evidence for Benefits

Blood Sugar Control in Type 2 Diabetes

The evidence for cinnamon's effect on blood sugar in type 2 diabetes is mixed, with several trials showing benefit and others showing no effect. Study design, cinnamon species, dose, form, duration, and the patients' concurrent medications all influence outcomes.

Positive Trials

Khan et al. (2003) — A study in Pakistan among 60 men and women with type 2 diabetes (average age 52) taking sulfonylurea drugs (glibenclamide) found that 1, 3, or 6 grams per day of ground Cinnamomum cassia in capsules taken in divided doses after meals for approximately 40 days produced significant reductions in fasting glucose (18-29%), triglycerides (23-30%), LDL cholesterol (7-27%), and total cholesterol (12-26%). All three doses produced similar benefits, with no changes in the placebo group [20].

Lu et al. (2012) — A three-month study in men and women aged 48 or older with type 2 diabetes taking gliclazide (30 mg/day) found that 120 mg or 360 mg of cassia cinnamon extract (40:1 water extract from Cinnamomum cassia) taken before breakfast significantly reduced fasting blood sugar and HbA1c compared to placebo. The low-dose group (120 mg extract) had an average fasting glucose reduction of 1.01 mmol/L (from 9.0 to 7.99 mmol/L) and a 0.67% reduction in HbA1c (from 8.9% to 8.23%). The high-dose group (360 mg extract) saw a larger fasting glucose reduction of 1.62 mmol/L (from 11.21 to 9.59 mmol/L) and a 0.92% HbA1c reduction (from 8.92% to 8.00%). Triglycerides decreased significantly only in the lower-dose group; no changes were observed in total cholesterol, HDL, or LDL [21].

Akilen et al. (2010) — A three-month trial in adults with type 2 diabetes on oral hypoglycemic medication with HbA1c above 7% randomized participants to 2 grams per day of cassia cinnamon (Cinnamomum cassia) powder (500 mg capsules: one with breakfast, two with lunch, one with dinner) or placebo. HbA1c decreased significantly from 8.22% to 7.86% in the cinnamon group, while it slightly increased in the placebo group. Fasting blood sugar was not significantly reduced compared to placebo, possibly because the starch-based placebo itself lowered fasting glucose. There was also a small but significant decrease in both systolic and diastolic blood pressure in the cinnamon group [22].

Crawford (2009) — A three-month study in men and women (average age 60) with poorly controlled type 2 diabetes found that 1 gram per day of cassia cinnamon (Cinnamomum cassia) in two 500-mg capsules taken with food, in addition to standard care, reduced HbA1c from 8.47% to 7.63%. This was a somewhat greater decrease than that observed in the standard-care-only group (8.28% to 7.91%) [23].

Mandal et al. (2023) — A study of 132 men and women (average age 53) with non-insulin-dependent type 2 diabetes found that 1,500 mg per day of Ceylon cinnamon (C. zeylanicum) bark powder taken as capsules on an empty stomach in the morning for approximately 4 months produced greater reductions in fasting blood sugar (-35 mg/dL versus -5 mg/dL) and modest reductions in HbA1c (-0.85% versus +0.15%) compared to placebo. This is one of the few studies suggesting Ceylon cinnamon — not just cassia — may have blood sugar-lowering effects [11].

Negative Trials

Vanschoonbeek et al. (2006) — A study in postmenopausal women with type 2 diabetes on oral blood sugar-lowering medication or dietary management found that 1.5 grams per day of cassia cinnamon (Cinnamomum cassia) taken as 500 mg capsules with each meal for 6 weeks did not improve oral glucose tolerance or measures of whole-body insulin sensitivity [24].

Blevins et al. (2007) — A study in adults with type 2 diabetes found that 1 gram per day of cassia cinnamon (Cinnamomum cassia) taken as 500 mg capsules with breakfast and dinner for 40 days had no effect on BMI, HbA1c, triglycerides, cholesterol, or insulin levels compared to placebo [25].

Wainstein et al. (2011) — A three-month trial in people with type 2 diabetes found that 1,200 mg per day of cassia cinnamon (Cinnamomum cassia) did not significantly decrease blood pressure [26].

Acute Blood Sugar Response

Solomon et al. (2007) — A small study found that 5 grams of cassia cinnamon taken with glucose during an oral glucose tolerance test (OGTT) significantly reduced the blood sugar response [27].

Rachid et al. (2022) — A study in 36 men and women with type 2 diabetes in Portugal found that consuming 100 mL of a liquid extract made from soaking 6 grams of cassia cinnamon (Cinnamomum burmannii) did not reduce blood sugar response during an OGTT compared to placebo [28].

Wickenberg et al. (2012) — A study using 6 grams of Ceylon cinnamon in capsules found no effect on blood sugar levels during an OGTT in people with impaired glucose tolerance [29].

Meta-Analysis

Allen et al. (2013) — A systematic analysis of 10 clinical trials concluded that cinnamon doses between 120 mg extract and 6 grams of bark powder per day "may have a beneficial effect on fasting plasma glucose, LDL-C, HDL-C, and triglyceride levels in patients with type 2 diabetes," but found no statistically significant effect on HbA1c across the pooled studies [30].

The evidence for cinnamon in type 2 diabetes is inconsistent. Positive trials tend to use cassia cinnamon at 1-6 grams per day for at least 1-3 months, in patients already taking oral hypoglycemic medications. The most consistent effects are reductions in fasting blood sugar and modest improvements in lipid parameters. HbA1c effects are small and not consistently significant across meta-analyses. One study suggests Ceylon cinnamon may also be effective at 1,500 mg/day, but this requires replication.

Blood Sugar Control in Prediabetes

Ziegenfuss et al. (2006) — A three-month study in prediabetic men and women with metabolic syndrome found that 500 mg per day of Cinnulin PF (a water-soluble 20:1 extract of Cinnamomum cassia standardized to 1% type-A PACs), taken as two 250-mg capsules with breakfast and dinner, significantly decreased fasting blood sugar by approximately 10 mg/dL, reduced systolic blood pressure by approximately 5 mmHg, and increased lean body mass by approximately 1 kg compared to placebo. No adverse events were reported [13].

Anderson et al. (2016) — A study in China among adults with elevated blood sugar found that 250 mg twice daily of CinSulin (a water extract of cassia cinnamon) modestly reduced average fasting blood sugar from 8.85 to 8.19 mmol/L. However, the researchers failed to determine statistical significance relative to placebo (whose levels also fell from 8.57 to 8.44 mmol/L) [14].

Romeo et al. (2020) — A three-month study in the U.S. and South Korea among 51 men and women (average age 52) with prediabetes found that fasting blood sugar levels increased in the placebo group but remained stable in those taking 500 mg cinnamon capsules three times daily. After three months, fasting glucose was approximately 5 mg/dL lower in the cinnamon group (108 vs 114 mg/dL). Cinnamon also modestly suppressed postprandial glucose increases and produced a small but significant decrease (-0.2%) in HbA1c. No improvement in HOMA-IR was observed [31].

Zelicha et al. (2024) — A study of 18 men and women with prediabetes (average age 51) found that 2 grams of cassia cinnamon (C. burmannii) powder twice daily with breakfast and dinner for four weeks did not improve 3-hour oral glucose tolerance tests, but did reduce 24-hour blood sugar concentrations compared to placebo [32].

In prediabetes, standardized cinnamon extracts (Cinnulin PF, CinSulin) at 250-500 mg/day show modest but consistent reductions in fasting blood sugar. The effects are small — typically 5-10 mg/dL reductions in fasting glucose — and insufficient to replace lifestyle interventions or pharmacotherapy, but may serve as a low-risk adjunctive measure.

Cholesterol and Lipid Effects

The Khan et al. (2003) study showed significant reductions in triglycerides (23-30%), LDL cholesterol (7-27%), and total cholesterol (12-26%) with 1-6 grams per day of cassia cinnamon over 40 days in patients with type 2 diabetes [20]. The Lu et al. (2012) study found that only the lower dose (120 mg extract) significantly reduced triglycerides, with no lipid effects at the higher dose [21].

Systematic reviews of cinnamon's lipid effects report capacity to lower total cholesterol by approximately 15-20 mg/dL, LDL cholesterol by 10-15 mg/dL, and triglycerides by 20-30 mg/dL in patients with metabolic disorders, based on interventions of 1-3 grams daily for 8-12 weeks [2][33][34]. These improvements are linked to inhibition of lipid peroxidation and enhanced hepatic lipid metabolism [35]. Evidence for HDL cholesterol elevation remains inconsistent across trials [36].

The Allen et al. (2013) meta-analysis of 10 trials found potential beneficial effects on LDL-C, HDL-C, and triglyceride levels, though the heterogeneity of results limits strong conclusions [30].

Antioxidant and Anti-Inflammatory Effects

Laboratory and animal studies consistently demonstrate that cinnamon has antioxidant and anti-inflammatory activity, mediated primarily through its polyphenolic content (PACs, catechins, protocatechuic acid) and cinnamaldehyde [37][2].

Meta-analyses of clinical trials indicate that 1-3 grams of cinnamon daily for 8-12 weeks reduces oxidative stress markers such as malondialdehyde (MDA) and increases total antioxidant capacity [2][38]. Additionally, meta-analyses show lowered levels of inflammatory cytokines including TNF-alpha and C-reactive protein (CRP), potentially through modulation of NF-kB inflammatory pathways [2][38][39].

Shishehbor et al. (2018) — A study in Iran among 36 women with rheumatoid arthritis already taking disease-modifying antirheumatic drugs found that 2 grams per day of cassia cinnamon (Cinnamomum burmannii) for two months significantly decreased self-reported pain by an average of 25 points (out of 100), reduced swollen joints by seven and tender joints by eight, and lowered the Disease Activity Score from 6.04 to 3.92. The cinnamon group also had significant decreases in blood CRP and TNF-alpha compared to placebo [40].

These anti-inflammatory and antioxidant effects may contribute to cardiovascular risk reduction, including modest systolic blood pressure decreases of 3-5 mmHg observed in some hypertensive populations [2][38].

Blood Pressure

Evidence for cinnamon's effect on blood pressure is limited and comes primarily as secondary outcomes from diabetes trials. The Akilen et al. (2010) study found small but significant reductions in both systolic and diastolic blood pressure with 2 grams/day of cassia cinnamon [22]. The Ziegenfuss et al. (2006) study found a significant ~5 mmHg reduction in systolic blood pressure with Cinnulin PF [13]. However, the Wainstein et al. (2011) study found no blood pressure reduction with 1,200 mg/day of cassia cinnamon over 3 months [26]. Systematic reviews suggest potential modest systolic blood pressure reductions of 3-5 mmHg in hypertensive individuals, but this evidence is preliminary and inconsistent [2][38].

Body Weight and Obesity

The Ziegenfuss et al. (2006) Cinnulin PF trial found a significant increase in lean body mass (approximately 1 kg) over 3 months [13]. Meta-analyses report small reductions in body weight (0.5-1 kg), BMI, and waist circumference after 12 weeks at 1.5-3 grams per day, possibly through appetite suppression and improved thermogenesis [2][41]. These effects are too small to be clinically meaningful as a standalone weight-loss intervention.

Antimicrobial Activity

Cinnamon — especially cinnamon oil — contains cinnamaldehyde, which demonstrates antimicrobial activity in laboratory settings against Candida species, E. coli, and other pathogens [42][43][2]. The use of cinnamon gum and candies has been reported to improve oral candidiasis in several people with HIV [44], though this evidence is limited to case reports. Antimicrobial properties are primarily demonstrated in vitro [2][42].

Cognitive Function

PACs from cinnamon may help inhibit the formation of advanced glycation end products (AGEs), thought to play a role in diabetes, atherosclerosis, and Alzheimer's disease [45]. Ceylon cinnamon extract has been found to reduce oxidative stress markers and improve cognitive measures in rats [46][47]. A 2024 systematic review of 40 studies found that cinnamon or its components significantly improved cognitive function — particularly memory and learning — in most preclinical cases, through anti-inflammatory effects, inhibition of amyloid-beta plaque formation, and brain signaling modulation [2][48]. However, no well-designed human clinical trials have demonstrated cognitive benefits of cinnamon supplementation [1][2][48].

Gastrointestinal Effects

Animal studies in IBS-D rat models have shown that aqueous cinnamon extract reduces diarrhea and bowel dysfunction by inhibiting serotonin synthesis [49]. A 2023 RCT found that Cinnamomum cassia water extract improved diarrhea symptoms by increasing colonic transit time and modulating gut microbiota, though some symptom scores were not statistically significant versus placebo [50]. No large-scale human trials confirm efficacy for IBS or functional GI disorders.

Recommended Dosing

By Indication

Type 2 diabetes (adjunctive to medication):

• Ground cassia cinnamon bark powder: 1-2 grams per day in divided doses with meals [20][22][23]
• Cassia cinnamon extract (40:1): 120-360 mg per day [21]
• Ceylon cinnamon bark powder: 1,500 mg per day (based on limited evidence from one trial) [11]

Prediabetes / elevated fasting glucose:

• Cinnulin PF extract: 250 mg twice daily (500 mg/day) [13]
• CinSulin extract: 250 mg twice daily [14]
• Ground cassia bark powder: 1,500 mg three times daily [31]

General blood sugar support: Cinnamon is typically taken shortly before, during, or shortly after eating. The dose is usually divided into at least two servings per day, taken around mealtimes [1].

Dosing Considerations

• Minimum effective dose: Most positive studies used at least 1 gram per day of ground bark or 120 mg per day of concentrated extract [1][30]
• Upper end of studied range: Up to 6 grams per day has been used short-term without serious adverse effects, but chronic use at this dose is not recommended due to coumarin exposure [1][20][27]
• Coumarin limits: EFSA tolerable daily intake is 0.1 mg/kg body weight (7 mg/day for a 70 kg adult). Up to 1 gram (~1/2 teaspoon) of ground cassia cinnamon is unlikely to exceed this limit. Cassia doses above 1-2 g/day should use Ceylon cinnamon instead [5][10]
• Form matters: Ground powder mixed in water may act faster for acute effects, while capsules and extracts are better suited for chronic use [12]

How to Read a Cinnamon Supplement Label

Key information to check: (1) Species of cinnamon — Ceylon has substantially less coumarin than cassia; (2) Form — standardized extracts provide more consistent PAC delivery than bark powder; (3) Amount per serving in mg or g, including concentration ratio for extracts; (4) Standardization to PACs if available; (5) Coumarin content, rarely listed but important for cassia products at higher doses. Note: Cinnamon oil products lack PACs and are not suitable for oral supplementation [1][17].

Safety and Side Effects

General Safety Profile

Single-ingredient cinnamon products made from cassia cinnamon are believed to be generally safe short-term at doses as high as 6 grams per day, with few side effects reported in clinical studies [1].

Common Side Effects

Side effects reported in clinical studies using cassia or Ceylon cinnamon include gastrointestinal discomfort (stomachache, nausea, constipation, heartburn), headache, and skin reactions (hives and rash) [51]. Long-term safety studies have not been conducted.

Coumarin Toxicity

The primary safety concern with cinnamon — particularly cassia varieties — is chronic coumarin exposure [1][5][10].

Safe intake thresholds: EFSA tolerable daily intake is 0.1 mg coumarin per kg body weight (7 mg/day for a 70 kg adult) [5][10]. Up to 1 gram (~1/2 teaspoon) per day of ground cassia cinnamon is unlikely to exceed this limit [1]. A small percentage of individuals sensitive to coumarin may develop elevated liver enzymes at lower intakes (5 mg or more per day) [1][10]. Daily intakes of 25-30 mg coumarin have been associated with liver damage, liver failure, and in some cases death [1].

Risk factors for coumarin sensitivity: immune system reactions, genetic variation of the CYP2A6 protein, previous alcohol-related liver damage, or viral hepatitis [10].

Species-specific risk: Ceylon cinnamon has negligible coumarin and is safe even at high doses. Chinese cassia (C. cassia) has moderate coumarin (0.1-0.8%), requiring caution above 1 g/day. Indonesian cassia (C. burmannii) has higher coumarin (0.2-1.0%), limiting safe consumption to ~1 teaspoon/day. Saigon cassia (C. loureiroi) has the highest coumarin (up to 6-7 mg/g) and the greatest toxicity risk [1][2][4][5].

Anticoagulant Effects

The coumarin in cinnamon is a natural anticoagulant that may increase bleeding risk, especially during or after surgery [1][9]. A 49-year-old man who had been taking a full tablespoon of Ceylon cinnamon daily for 10 months experienced postoperative hemorrhage after colon surgery. His clotting times were far beyond normal range. He was treated with blood product infusions and eventually stabilized [52].

Liver Damage Risk

A 71-year-old woman taking high-dose rosuvastatin (40 mg) developed hepatitis one week after beginning a daily cinnamon supplement. The hepatitis resolved after stopping both the statin and cinnamon, after which she was able to resume the statin without problems [53].

Edema

Cinnamon may affect blood sugar and insulin through mechanisms similar to thiazolidinedione drugs, which can cause edema. A 57-year-old man with hypertension and type 2 diabetes developed leg edema after taking 1,000 mg of Cinnamomum cassia bark powder for one week, which resolved within five days of stopping supplementation [54].

Other Adverse Effects

• Rosacea exacerbation: Reported in a 68-year-old woman after two weeks of cinnamon oil supplementation [55]
• CNS depression: Animal studies show large doses of cinnamon oil can depress the central nervous system [56]
• Allergic reactions: Cinnamaldehyde can trigger urticaria, dermatitis, oral stomatitis, or anaphylaxis [2][57]
• Aspiration risk: The "cinnamon challenge" causes acute respiratory inflammation with documented pediatric cases of temporary scarring [2][58]

Lead Contamination

Certain ground cinnamon products have been found contaminated with elevated lead levels. A 2023-2024 outbreak linked cinnamon-adulterated applesauce to over 500 pediatric lead poisoning cases, some requiring chelation therapy [2][59][60]. This underscores the importance of sourcing cinnamon from reputable manufacturers with third-party testing.

Special Populations

• Pregnancy and breastfeeding: Safety not established; avoid cinnamon oil or high doses of bark powder [1]
• Liver disease: Use with extra caution due to coumarin hepatotoxicity risk [1][10]
• Pre-surgical patients: Discontinue at least two weeks before surgery due to anticoagulant and blood sugar-lowering effects [1]

Drug Interactions

Cinnamon can interact with several medication classes. The primary concerns are additive blood sugar lowering, anticoagulant effects from coumarin, and potential liver toxicity with hepatotoxic drugs.

Blood Sugar-Lowering Medications

Because cassia cinnamon may lower blood sugar, it should be used with caution in people taking antidiabetic medications [1][2]:

Drug Class	Examples	Interaction	Clinical Implication
Sulfonylureas	Glibenclamide, gliclazide	Additive hypoglycemia	Monitor blood sugar closely; positive studies were conducted with these drugs [20][21]
Biguanides	Metformin	Additive blood sugar lowering	Watch for hypoglycemia symptoms: headache, dizziness, tremor [2][61]
Insulin	All forms	Additive hypoglycemia	Increased risk of low blood sugar episodes
Thiazolidinediones	Pioglitazone (Actos)	Additive effects and shared side effects	Risk of fluid retention and edema [1][54]
SGLT2 inhibitors	Empagliflozin, dapagliflozin	Theoretical additive effect	Limited evidence; monitor glucose
GLP-1 agonists	Semaglutide, liraglutide	Theoretical additive effect	Limited evidence; monitor glucose

Anticoagulant and Antiplatelet Drugs

The coumarin in cinnamon interferes with vitamin K-dependent clotting factor synthesis — the same mechanism as warfarin [1][9][2]:

Drug	Risk	Note
Warfarin (Coumadin)	Increased bleeding risk	Coumarin acts via the same pathway; INR should be monitored [9][61]
Heparin, enoxaparin	Theoretical additive risk	Less evidence than with warfarin
Aspirin, clopidogrel	Theoretical additive bleeding	Monitor for signs of bleeding
NSAIDs	Additive GI bleeding risk	Standard caution

Hepatotoxic Drugs

High-coumarin cinnamon varieties may compound liver toxicity with concurrent hepatotoxic medications, including statins (particularly high-dose rosuvastatin — case report of hepatitis with combined use [53]), high-dose acetaminophen, and other liver-metabolized pharmaceuticals [2][53][61].

Blood Pressure-Lowering Medications

Cinnamon's modest hypotensive effects could theoretically amplify blood pressure-lowering drugs, though this has not been well-documented clinically [2][22][13].

General Guidance

Culinary amounts of cinnamon generally pose minimal interaction risk [2]. Supplemental doses exceeding 1-2 grams daily warrant more caution in people taking multiple medications [2]. Always inform your healthcare provider about cinnamon supplement use, especially before surgery or when starting new medications.

Dietary Sources

Cinnamon is consumed as a spice rather than a primary nutrient source. However, it contains notable amounts of certain minerals and bioactive compounds.

Nutritional Composition of Ground Cinnamon (per 100 g)

Nutrient	Amount	% Daily Value
Calories	261 kcal	—
Carbohydrates	79.85 g	—
Dietary Fiber	53.1 g	—
Protein	3.89 g	—
Total Fat	3.19 g	—
Manganese	17.5 mg	760%
Calcium	1,002 mg	100%
Iron	8.3 mg	46%
Potassium	431 mg	13%
Magnesium	60 mg	14%

Source: USDA FoodData Central [2][62]. Based on a 2,000-calorie diet. One teaspoon of ground cinnamon weighs approximately 2.6 grams and contains about 6 calories.

The exceptionally high manganese content is noteworthy: a single teaspoon provides approximately 0.46 mg of manganese, about 20% of the daily value. Ceylon cinnamon exhibits a broadly similar nutritional profile, though some analyses indicate potentially higher protein levels (up to 9.45 g per 100 g versus 3.99 g in cassia) [2][63].

Key Bioactive Components

Component	Function	Concentration
Cinnamaldehyde	Antimicrobial, anti-inflammatory, flavor	65-95% of essential oil (higher in cassia)
Proanthocyanidins (PACs)	Insulin-enhancing, antioxidant	Higher in water extracts; variable in bark powder
Coumarin	Natural anticoagulant; hepatotoxic at high doses	0.004% (Ceylon) to 1%+ (cassia)
Eugenol	Anti-inflammatory, analgesic	Up to 10% in leaf oils
Cinnamic acid	Antioxidant	Minor component

Culinary Uses

• Baked goods: Cinnamon rolls, apple pie, cookies, muffins — cassia preferred for stronger flavor
• Beverages: Chai tea, hot chocolate, mulled wine, cider — sticks commonly steeped
• Savory dishes: Moroccan tagines, Indian curries, Chinese five-spice, Mexican cochinita pibil
• Breakfast foods: Oatmeal, yogurt, smoothies, toast
• Preservation: Natural antimicrobial properties historically used for food preservation

Practical Considerations

Cassia vs Ceylon in cooking: Cassia is the default "cinnamon" in most grocery stores. For occasional baking, cassia is fine. For daily use (e.g., added to oatmeal every morning), Ceylon is safer due to lower coumarin [1][2]. Cinnamon sticks steeped in beverages release less coumarin than ground powder, especially in non-alcoholic, non-fatty beverages. Store ground cinnamon in airtight containers away from heat and light; whole sticks retain bioactivity longer [2].

References

1. ConsumerLab. "Cinnamon Supplements Review." Accessed 2025. https://www.consumerlab.com/reviews/cinnamon-supplements-review/cinnamon/

2. Grokipedia. "Cinnamon." https://grokipedia.com/page/Cinnamon

3. Kawatra P, Rajagopalan R. "Cinnamon: Mystic powers of a minute ingredient." Pharmacognosy Res. 2015;7(Suppl 1):S1-S6. https://pubmed.ncbi.nlm.nih.gov/26109781/

4. Differentiation of the Four Major Species of Cinnamons (C. burmannii, C. verum, C. cassia, and C. loureiroi). NIH/PubMed.

5. European Food Safety Authority (EFSA). "Coumarin in flavourings and other food ingredients with flavouring properties." EFSA Journal. 2008.

6. Anderson RA, et al. "Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity." J Agric Food Chem. 2004;52(1):65-70. https://doi.org/10.1021/jf034916b

7. Ercan P, El SN. "Inhibitory effects of chickpea and Tribulus terrestris on lipase, alpha-amylase and alpha-glucosidase." Int J Vitam Nutr Res. 2021.

8. Cinnamaldehyde. PubChem, NIH. https://pubchem.ncbi.nlm.nih.gov/compound/637511

9. Maadarani O, et al. "Coumarin compounds in cinnamon and effects on coagulation." Eur J Case Rep Intern Med. 2019. https://doi.org/10.12890/2019_001044

10. Abraham K, et al. "Toxicology and risk assessment of coumarin: focus on human data." Mol Nutr Food Res. 2010;54(2):228-239. https://doi.org/10.1002/mnfr.200900281

11. Mandal S, et al. "Effect of cinnamon (Cinnamomum zeylanicum) supplementation on fasting blood glucose and HbA1c in type 2 diabetes patients." Cureus. 2023. https://doi.org/10.7759/cureus.47822

12. Moreira TMCL, et al. "Ground cinnamon reduces postprandial glucose: powder versus capsule form." PLOS ONE. 2024. https://doi.org/10.1371/journal.pone.0297556

13. Ziegenfuss TN, et al. "Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women." J Int Soc Sports Nutr. 2006;3(2):45-53. https://doi.org/10.1186/1550-2783-3-2-45

14. Anderson RA, et al. "Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose." J Trad Compl Med. 2016;6(4):332-336. https://doi.org/10.1016/j.jtcme.2015.03.005

15. Leela NK. "Cinnamon and Cassia." In: Chemistry of Spices. 2008.

16. PubChem. Coumarin compound summary. https://pubchem.ncbi.nlm.nih.gov/compound/323

17. Zhao J, et al. "Analysis of cinnamon oil composition." Arabian J Chem. 2020. https://doi.org/10.1016/j.arabjc.2020.10.007

18. Ballin NZ, Sorensen AT. "Coumarin content in cinnamon containing food products on the Danish market." Food Control. 2014;38:198-203. https://doi.org/10.1016/j.foodcont.2013.10.014

19. Assessment of Coumarin Levels in Ground Cinnamon Available in the Czech Republic. NIH/PubMed.

20. Khan A, et al. "Cinnamon improves glucose and lipids of people with type 2 diabetes." Diabetes Care. 2003;26(12):3215-3218. https://doi.org/10.2337/diacare.26.12.3215

21. Lu T, et al. "Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes." Nutr Res. 2012;32(6):408-412. https://doi.org/10.1016/j.nutres.2012.05.003

22. Akilen R, et al. "Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic type 2 diabetic patients in the UK." Diabet Med. 2010;27(10):1159-1167. https://doi.org/10.1111/j.1464-5491.2010.03079.x

23. Crawford P. "Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes." J Am Board Fam Med. 2009;22(5):507-512. https://doi.org/10.3122/jabfm.2009.05.080093

24. Vanschoonbeek K, et al. "Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients." J Nutr. 2006;136(4):977-980. https://doi.org/10.1093/jn/136.4.977

25. Blevins SM, et al. "Effect of cinnamon on glucose and lipid levels in non-insulin-dependent type 2 diabetes." Diabetes Care. 2007;30(9):2236-2237. https://doi.org/10.2337/dc07-0098

26. Wainstein J, et al. "Effects of cinnamon supplementation on blood pressure in patients with type 2 diabetes mellitus." J Med Food. 2011.

27. Solomon TPJ, Blannin AK. "Effects of short-term cinnamon ingestion on in vivo glucose tolerance." Diabetes Obes Metab. 2007;9(6):895-901. https://doi.org/10.1111/j.1463-1326.2006.00694.x

28. Rachid AP, et al. "Effect of aqueous cinnamon extract on glucose tolerance test in type 2 diabetes patients." Nutrients. 2022. https://doi.org/10.3390/nu14204117

29. Wickenberg J, et al. "Ceylon cinnamon does not affect postprandial blood glucose in subjects with impaired glucose tolerance." Br J Nutr. 2012.

30. Allen RW, et al. "Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis." Ann Fam Med. 2013;11(5):452-459. https://doi.org/10.1370/afm.1517

31. Romeo GR, et al. "Influence of cinnamon on glycemic control in individuals with prediabetes." J Endocr Soc. 2020;4(11):bvaa094. https://doi.org/10.1210/jendso/bvaa094

32. Zelicha H, et al. "The effect of cinnamon on glucose metabolism in adults with prediabetes." Am J Clin Nutr. 2024. https://doi.org/10.1016/j.ajcnut.2024.01.015

33. Cinnamon Use in Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis. NIH/PubMed.

34. The Effects of Cinnamon on Patients with Metabolic Diseases. NIH/PubMed.

35. Cinnamon Polyphenol Extract Inhibits Hyperlipidemia. NIH/PubMed.

36. Effects of Cinnamon Supplementation on Lipid Profile: A Systematic Review and Meta-Analysis. NIH/PubMed.

37. Kawatra P, Rajagopalan R. "Cinnamon: Mystic powers of a minute ingredient." Pharmacognosy Res. 2015;7(Suppl 1):S1-S6. https://pubmed.ncbi.nlm.nih.gov/26109781/

38. A Systematic Review and Meta-Analysis of Randomized Controlled Trials on cinnamon supplementation and cardiovascular risk factors. NIH/PubMed.

39. Anti-Inflammatory Properties of Cinnamon Polyphenols and their Monomeric Precursors. NIH/PubMed.

40. Shishehbor F, et al. "Cinnamon supplementation improves clinical symptoms and inflammatory markers in women with rheumatoid arthritis." J Am Coll Nutr. 2018;37(8):685-690. https://doi.org/10.1080/07315724.2018.1460733

41. Cinnamon supplementation positively affects obesity: A systematic review and dose-response meta-analysis. NIH/PubMed.

42. Nuryastuti T, et al. "Effect of cinnamon oil on biofilm formation." Appl Environ Microbiol. 2009.

43. Muthuswamy S, et al. "Antimicrobial activity of cinnamon." J Food Safety. 2008.

44. Quale JM, et al. "In vitro activity of Cinnamomum zeylanicum against azole resistant and sensitive Candida species." Am J Chin Med. 1996;24(2):103-109. https://doi.org/10.1142/S0192415X96000153

45. Peng X, et al. "Inhibitory effect of cinnamon bark extract on advanced glycation end products formation." J Agric Food Chem. 2010.

46. Jain S, et al. "Neuroprotective effects of cinnamon." Nutr Neurosci. 2015.

47. Malik J, et al. "Effects of a cinnamon extract on cognitive function." J Basic Clin Physiol Pharmacol. 2015.

48. Systematic review of cinnamon and cognitive function (2024). 40 studies analyzed.

49. Aqueous cinnamon extract ameliorates bowel dysfunction and enteric 5-HT synthesis in IBS rats. NIH/PubMed.

50. Cinnamon (Cinnamomum cassia) water extract improves diarrhea symptoms: a randomized controlled trial. 2023. NIH/PubMed.

51. Hajimonfarednejad M, et al. "Cinnamon: a systematic review of adverse events." Clin Nutr. 2018. https://doi.org/10.1016/j.clnu.2018.09.003

52. Chase CK, et al. "Cinnamon-associated coagulopathy and postoperative hemorrhage." Int J Surg Case Rep. 2022. https://doi.org/10.1016/j.ijscr.2022.107432

53. Brancheau D, et al. "Cinnamon-induced hepatitis in an older woman." Am J Case Rep. 2015;16:250-252. https://doi.org/10.12659/AJCR.893261

54. Crawford P. "Cinnamon bark powder and edema." J Am Board Fam Med. 2018.

55. Campbell TM, et al. "Cinnamon oil-induced rosacea exacerbation." J Drugs Dermatol. 2008.

56. Harada M, Ozaki Y. "Pharmacological studies on Chinese cinnamon: central effects." J Pharmacobiodyn. 1982;5(8):539-546.

57. Cinnamon allergy: Symptoms, diagnosis, and treatment.

58. Ingesting and Aspirating Dry Cinnamon by Children and Adolescents. NIH/PubMed.

59. FDA Alert Concerning Certain Cinnamon Products Due to Elevated Lead Levels. U.S. FDA.

60. Investigation of Lead and Chromium Exposure After Contaminated Cinnamon Products. CDC/MMWR.

61. Cinnamon Interactions Checker. Drugs.com. https://www.drugs.com/interactions-check.php

62. U.S. Department of Agriculture, FoodData Central. Cinnamon, ground. https://fdc.nal.usda.gov/

63. Differentiation of the Four Major Species of Cinnamons: nutritional comparison. NIH/PubMed.